CASE REPORT| Volume 14, ISSUE 1, P51-53, March 2005

Download started.


Polycythaemia Vera Presenting as ST-Elevation Myocardial Infarction


      A case of ST-elevation myocardial infarction as the first presentation of polycythaemia vera is described. The discussion summarises the evidence for the safety and efficacy of contemporary ST-elevation treatment strategies in the setting of polycythaemia vera.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zinn P.
        • Applegate R.J.
        • Walsh R.A.
        Acute total aortic occlusion during cardiac catheterization associated with polycythemia vera.
        Cathet Cardiovasc Diagn. 1988; 14: 108-110
        • Zavalloni D.
        • Marsico F.
        • Milone F.
        • Presbitero P.
        Is conventional antiplatelet therapy for the prevention of coronary stent thrombosis always safe? A case report of a patient with polycythemia vera.
        Ital Heart J. 2004; 5: 163-166
        • Goethals P.
        • Evrard S.
        • Dubois C.
        Recurrent coronary stent thrombosis.
        Acta Cardiol. 2000; 55: 371-373
      1. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995;123:656–64.

        • Spivak J.
        Daily aspirin—only half the answer.
        N Engl J Med. 2004; 350: 99-101
        • Landolfi R.
        • Marchioli R.
        • Kutti J.
        • Gisslinger H.
        • Tognoni G.
        • Patrono C.
        • et al.
        Efficacy and safety of low-dose aspirin in polycythemia vera.
        N Engl J Med. 2004; 350: 114-124
        • Chan A.W.
        • Drobac M.
        • Sternberg L.
        The management of acute myocardial infarction in a patient with polycythemia rubra vera during the thrombolytic era—does it make a difference?.
        Can J Cardiol. 1997; 13: 59-63
        • Ali M.
        • Fayemi A.O.
        • Malcolm D.
        • Braun E.V.
        Intraventricular thrombosis in polycythemia vera: a cause of intractable cardiac failure.
        Am Heart J. 1980; 100: 520-522
        • Watson K.V.
        • Key N.
        Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.
        Br J Haematol. 1993; 83: 198-203